Cargando…
Update on Melasma—Part II: Treatment
Melasma is a prevalent chronic relapsing pigmentary disorder that affects photoexposed areas, especially in women of childbearing age. Although there is currently no curative treatment available for melasma, this manuscript critically reviews the knowledge regarding photoprotection, topical and oral...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464276/ https://www.ncbi.nlm.nih.gov/pubmed/35906506 http://dx.doi.org/10.1007/s13555-022-00780-4 |
_version_ | 1784787547709243392 |
---|---|
author | Cassiano, Daniel P. Espósito, Ana Cláudia C. da Silva, Carolina N. Lima, Paula B. Dias, Joana A. F. Hassun, Karime Miot, Luciane D. B. Miot, Hélio A. Bagatin, Ediléia |
author_facet | Cassiano, Daniel P. Espósito, Ana Cláudia C. da Silva, Carolina N. Lima, Paula B. Dias, Joana A. F. Hassun, Karime Miot, Luciane D. B. Miot, Hélio A. Bagatin, Ediléia |
author_sort | Cassiano, Daniel P. |
collection | PubMed |
description | Melasma is a prevalent chronic relapsing pigmentary disorder that affects photoexposed areas, especially in women of childbearing age. Although there is currently no curative treatment available for melasma, this manuscript critically reviews the knowledge regarding photoprotection, topical and oral therapies, and procedures such as peelings, laser, and microneedling that represent the main strategies for control and prevention of this disease. As the pathogenesis of melasma is not entirely understood, there are prospects for the development of new therapeutic strategies that might act on the pathways that promote sustained pigmentation rather than merely decreasing melanin synthesis and removing melanin from the epidermis. |
format | Online Article Text |
id | pubmed-9464276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-94642762022-09-12 Update on Melasma—Part II: Treatment Cassiano, Daniel P. Espósito, Ana Cláudia C. da Silva, Carolina N. Lima, Paula B. Dias, Joana A. F. Hassun, Karime Miot, Luciane D. B. Miot, Hélio A. Bagatin, Ediléia Dermatol Ther (Heidelb) Review Melasma is a prevalent chronic relapsing pigmentary disorder that affects photoexposed areas, especially in women of childbearing age. Although there is currently no curative treatment available for melasma, this manuscript critically reviews the knowledge regarding photoprotection, topical and oral therapies, and procedures such as peelings, laser, and microneedling that represent the main strategies for control and prevention of this disease. As the pathogenesis of melasma is not entirely understood, there are prospects for the development of new therapeutic strategies that might act on the pathways that promote sustained pigmentation rather than merely decreasing melanin synthesis and removing melanin from the epidermis. Springer Healthcare 2022-07-29 /pmc/articles/PMC9464276/ /pubmed/35906506 http://dx.doi.org/10.1007/s13555-022-00780-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Review Cassiano, Daniel P. Espósito, Ana Cláudia C. da Silva, Carolina N. Lima, Paula B. Dias, Joana A. F. Hassun, Karime Miot, Luciane D. B. Miot, Hélio A. Bagatin, Ediléia Update on Melasma—Part II: Treatment |
title | Update on Melasma—Part II: Treatment |
title_full | Update on Melasma—Part II: Treatment |
title_fullStr | Update on Melasma—Part II: Treatment |
title_full_unstemmed | Update on Melasma—Part II: Treatment |
title_short | Update on Melasma—Part II: Treatment |
title_sort | update on melasma—part ii: treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464276/ https://www.ncbi.nlm.nih.gov/pubmed/35906506 http://dx.doi.org/10.1007/s13555-022-00780-4 |
work_keys_str_mv | AT cassianodanielp updateonmelasmapartiitreatment AT espositoanaclaudiac updateonmelasmapartiitreatment AT dasilvacarolinan updateonmelasmapartiitreatment AT limapaulab updateonmelasmapartiitreatment AT diasjoanaaf updateonmelasmapartiitreatment AT hassunkarime updateonmelasmapartiitreatment AT miotlucianedb updateonmelasmapartiitreatment AT miothelioa updateonmelasmapartiitreatment AT bagatinedileia updateonmelasmapartiitreatment |